ACI Proposes Combined Cash and Stock Payout as Group Loss Deepens
The company's standalone earnings improved, but higher expenses, borrowing costs and weaker subsidiary performance pushed consolidated loss per share to Tk 8.59.

Advanced Chemical Industries has put forward a dividend recommendation that balances a return to shareholders with the reality of a wider consolidated loss for the financial year ended 30 June 2026. The board's proposal, made after reviewing the audited accounts, calls for a total distribution equivalent to 20 percent of the face value of shares, split between cash and stock. The decision underscores the tension many diversified groups face when revenue expands but rising expenses and financing costs erode profitability at the consolidated level.
Under the recommendation, shareholders would receive a 15 percent cash dividend together with a 5 percent stock dividend. The proposal was approved at the company's 233rd board meeting, where directors also cleared the audited financial statements for the year. The record date has been set for 19 November, after which eligible holders will be determined for the distribution, subject to final approval by shareholders at the annual general meeting.
At the group level, the results show a clear deterioration in the bottom line. Consolidated loss per share widened by 16.1 percent to Tk 8.59 from Tk 7.40 in the preceding year. The increase in the loss occurred even though consolidated revenue rose 14.44 percent and gross profit advanced 20.29 percent. The improvement at the gross-profit stage indicates that core sales activity and pricing power remained reasonably healthy, yet those gains were more than offset further down the income statement. Higher operating expenses linked to inflation, additional spending on strategic initiatives, and elevated borrowing costs all contributed to the larger net loss for the consolidated entity.
The picture looks different when viewed through the parent company's standalone accounts. Standalone earnings per share increased 21.2 percent to Tk 55.17, and standalone net asset value per share climbed 16.1 percent to Tk 393.82. This divergence highlights the impact of subsidiaries and associates on the overall group result. While the parent continued to generate solid earnings, the performance of other units within the conglomerate pulled the consolidated figures into deeper loss territory. For investors who follow both sets of numbers, the contrast serves as a reminder that ACI's diversified structure can produce strong results in some segments while other businesses absorb higher costs or require ongoing investment.
The dividend recommendation itself can be read in more than one way. On one hand, the combination of cash and stock provides a tangible return at a time when the consolidated accounts show a loss, which may be welcomed by income-focused shareholders. The cash component offers immediate liquidity, while the stock element conserves some cash within the company and modestly increases the number of shares in issue. On the other hand, the wider loss and the reliance on standalone strength raise questions about the sustainability of payouts if cost pressures persist or if weaker units continue to weigh on the group. Many market participants are likely to watch subsequent quarterly updates for signs that operating expenses and financing charges are being brought under better control.
ACI's situation is not unusual among large Bangladeshi conglomerates that operate across pharmaceuticals, consumer goods, agriculture-related products and other sectors. Revenue growth of the magnitude reported here demonstrates continued demand for the group's offerings, yet the translation of that growth into net profit has been constrained by the broader cost environment. Inflation has lifted input and distribution expenses, while higher interest rates have increased the burden of debt. Strategic investments, although potentially beneficial over a longer horizon, also consume resources in the near term and can widen reported losses until those investments begin to contribute more meaningfully to earnings.
The board's decision to recommend a dividend despite the consolidated loss suggests directors believe the company's overall financial position remains adequate to support a distribution. The improvement in standalone net asset value provides some support for that view, as does the growth in revenue and gross profit. At the same time, the proposal leaves open the question of how the group will manage the trade-off between returning capital and retaining resources for future expansion or debt reduction. Shareholders will have the opportunity to consider these issues when the recommendation comes before the annual general meeting.
In the period ahead, attention is likely to focus on whether ACI can narrow the gap between its standalone and consolidated performance. Progress in controlling operating costs, optimising the financing mix, and improving the contribution of underperforming units would help convert top-line growth into stronger bottom-line results. Until clearer evidence of that improvement emerges, the market will continue to weigh the value of the proposed 20 percent combined dividend against the backdrop of a wider group loss. The recommendation keeps the company on a path of sharing returns with owners, but the durability of that path will depend on how effectively the group navigates the cost and investment challenges that have so far limited consolidated profitability.

